Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2025-07-10 00:00:00 ET · period of report 2025-07-08 · accession 0001005286-25-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-10 | 2025-07-08 | LFCR | Salus Thomas D. | Chief Legal, Administration | M - OptEx | — | +37.0K | 252.0K | +17% | — |
| D | 2025-07-10 | 2025-07-08 | LFCR | Salus Thomas D. | Chief Legal, Administration | F - Tax | $8.19 | -11.0K | 241.0K | -4% | -$90.3K |
| D | 2025-07-10 | 2025-07-08 | LFCR | Salus Thomas D. | Chief Legal, Administration | M - OptEx | — | -37.0K | 333.0K | -10% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-08 | M | A | 37,000 | — | 252,000 | D | — | — | (F1) The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone. (F2) Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices. |
| 2 | Common | Common Stock | 2025-07-08 | F | D | 11,022 | $8.19 | 240,978 | D | — | — | (F3) Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the performance stock unit award as reported in Table I. |
| 3 | Derivative | Performance-Based Restricted Stock Units | 2025-07-08 | M | D | 37,000 | — | 333,000 | D | — · — to 2030-04-14 | 37,000 Common Stock | (F2) Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices. |